HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akihiko Gemma Selected Research

Aspergillus niger infection

1/2022Acute respiratory failure due to Aspergillus niger infection with acute fibrinous and organazing pneumonia: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akihiko Gemma Research Topics

Disease

78Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 06/2003
61Lung Neoplasms (Lung Cancer)
04/2022 - 06/2003
47Neoplasms (Cancer)
01/2022 - 06/2003
35Interstitial Lung Diseases (Interstitial Lung Disease)
02/2021 - 08/2003
16Chronic Obstructive Pulmonary Disease (COPD)
10/2021 - 01/2011
16Adenocarcinoma
01/2020 - 06/2003
14Adenocarcinoma of Lung
04/2022 - 02/2007
14Idiopathic Pulmonary Fibrosis
09/2021 - 04/2009
12Disease Progression
03/2021 - 12/2009
11Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 06/2003
9Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 01/2012
9Pneumonia (Pneumonitis)
12/2019 - 03/2010
7Neoplasm Metastasis (Metastasis)
01/2021 - 06/2003
7Drug-Related Side Effects and Adverse Reactions
08/2020 - 07/2011
7Renal Cell Carcinoma (Grawitz Tumor)
08/2020 - 01/2013
7Dyspnea (Shortness of Breath)
12/2019 - 10/2011
7Lung Injury
11/2019 - 07/2008
7Emphysema
01/2018 - 02/2012
6Carcinogenesis
01/2021 - 08/2003
5Fever (Fevers)
11/2022 - 06/2008
5Fibrosis (Cirrhosis)
01/2021 - 06/2015
5Pleural Effusion (Pleural Effusions)
01/2021 - 04/2011
5Idiopathic Interstitial Pneumonias
04/2020 - 01/2009
5Neutropenia
05/2019 - 06/2008
5Malignant Mesothelioma
02/2019 - 06/2008
5Lung Diseases (Lung Disease)
01/2019 - 01/2011
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2016 - 09/2004
4Respiratory Insufficiency (Respiratory Failure)
01/2022 - 07/2012
4Inflammation (Inflammations)
01/2022 - 08/2012
4Brain Neoplasms (Brain Tumor)
01/2020 - 04/2016
4Nausea
01/2019 - 04/2014
4Infections
05/2018 - 03/2010
4Colorectal Neoplasms (Colorectal Cancer)
12/2015 - 08/2003
3Vomiting
04/2022 - 01/2016
3Organizing Pneumonia
01/2022 - 01/2019
3Mesothelioma
01/2021 - 06/2008
3Breast Neoplasms (Breast Cancer)
01/2020 - 06/2010
3Malignant Pleural Effusion
01/2020 - 04/2011
3Diarrhea
08/2019 - 05/2013
3Pulmonary Edema
01/2019 - 01/2014
3Exanthema (Rash)
01/2019 - 06/2010
3Carcinoma (Carcinomatosis)
11/2018 - 06/2008
3Multiple Myeloma
05/2018 - 12/2011
3Small Cell Carcinoma
01/2018 - 09/2004
3Pulmonary Hypertension
12/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

28ErbB Receptors (EGF Receptor)IBA
04/2022 - 08/2003
26Pharmaceutical PreparationsIBA
02/2021 - 06/2006
24Tyrosine Kinase InhibitorsIBA
04/2021 - 02/2007
23Carboplatin (JM8)FDA LinkGeneric
04/2022 - 06/2006
22Proteins (Proteins, Gene)FDA Link
03/2021 - 08/2003
22Gefitinib (Iressa)FDA Link
01/2021 - 08/2003
17Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2004
14Paclitaxel (Taxol)FDA LinkGeneric
12/2019 - 06/2006
13Biomarkers (Surrogate Marker)IBA
03/2022 - 12/2006
12Docetaxel (Taxotere)FDA Link
01/2020 - 06/2006
9osimertinibIBA
02/2022 - 01/2018
9Bevacizumab (Avastin)FDA Link
01/2020 - 02/2013
7pembrolizumabIBA
04/2022 - 01/2018
7Pemetrexed (MTA)FDA Link
02/2022 - 06/2008
7AfatinibIBA
04/2021 - 10/2018
7Anaplastic Lymphoma KinaseIBA
03/2021 - 05/2013
7MicroRNAs (MicroRNA)IBA
01/2021 - 07/2009
7Bleomycin (Blenoxane)FDA LinkGeneric
01/2021 - 04/2011
7Irinotecan (Camptosar)FDA LinkGeneric
05/2013 - 04/2004
6Adrenal Cortex Hormones (Corticosteroids)IBA
08/2022 - 07/2016
6GemcitabineFDA Link
01/2018 - 06/2006
5NivolumabIBA
11/2021 - 07/2017
5B7-H1 AntigenIBA
03/2020 - 01/2018
5CrizotinibIBA
07/2019 - 04/2015
5Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 11/2012
5DNA (Deoxyribonucleic Acid)IBA
08/2012 - 11/2003
4SteroidsIBA
01/2022 - 02/2009
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 01/2012
4Monoclonal AntibodiesIBA
01/2019 - 08/2015
4Vinorelbine (Navelbine)FDA LinkGeneric
01/2018 - 06/2006
4LigandsIBA
01/2018 - 12/2006
4Etoposide (VP 16)FDA LinkGeneric
10/2012 - 12/2007
4Histone Deacetylase InhibitorsIBA
06/2010 - 11/2007
4Complementary DNA (cDNA)IBA
01/2009 - 06/2003
3CytokinesIBA
08/2022 - 08/2007
3Albumin-Bound PaclitaxelFDA Link
04/2022 - 02/2019
3130-nm albumin-bound paclitaxelIBA
01/2022 - 08/2017
3Carbon MonoxideIBA
09/2021 - 01/2013
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2021 - 05/2012
3AsbestosIBA
01/2021 - 05/2015
3RNA (Ribonucleic Acid)IBA
01/2020 - 11/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 02/2013
3PlatinumIBA
05/2019 - 07/2015
3Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 10/2007
3pirfenidoneIBA
01/2018 - 02/2014
3Bosentan (Tracleer)FDA Link
12/2017 - 01/2015
3amrubicinIBA
07/2016 - 02/2009
3Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
06/2015 - 02/2012

Therapy/Procedure

52Therapeutics
08/2022 - 06/2003
39Drug Therapy (Chemotherapy)
04/2022 - 08/2003
6Aftercare (After-Treatment)
01/2019 - 12/2009
5Combination Drug Therapy (Combination Chemotherapy)
04/2020 - 12/2007
4Radiotherapy
01/2019 - 04/2011
3Activities of Daily Living (ADL)
12/2017 - 10/2011